DIVERSIFIED HEALTHCARE TRUST (DHC) Fundamental Analysis & Valuation
NASDAQ:DHC • US25525P1075
Current stock price
6.71 USD
-0.44 (-6.15%)
At close:
6.7568 USD
+0.05 (+0.7%)
After Hours:
This DHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DHC Profitability Analysis
1.1 Basic Checks
- In the past year DHC has reported negative net income.
- DHC had a negative operating cash flow in the past year.
- In the past 5 years DHC reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: DHC reported negative operating cash flow in multiple years.
1.2 Ratios
- DHC's Return On Assets of -6.56% is on the low side compared to the rest of the industry. DHC is outperformed by 84.55% of its industry peers.
- With a Return On Equity value of -17.16%, DHC is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -17.16% | ||
| ROIC | N/A |
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of DHC (18.11%) is worse than 91.87% of its industry peers.
- DHC's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for DHC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
2. DHC Health Analysis
2.1 Basic Checks
- DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- DHC has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, DHC has more shares outstanding
- DHC has a better debt/assets ratio than last year.
2.2 Solvency
- DHC has an Altman-Z score of -0.22. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of DHC (-0.22) is worse than 76.42% of its industry peers.
- DHC has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
- DHC has a Debt to Equity ratio (1.44) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.22 |
ROIC/WACCN/A
WACC9.07%
2.3 Liquidity
- DHC has a Current Ratio of 1.56. This is a normal value and indicates that DHC is financially healthy and should not expect problems in meeting its short term obligations.
- DHC's Current ratio of 1.56 is amongst the best of the industry. DHC outperforms 82.93% of its industry peers.
- DHC has a Quick Ratio of 1.56. This is a normal value and indicates that DHC is financially healthy and should not expect problems in meeting its short term obligations.
- DHC has a Quick ratio of 1.56. This is amongst the best in the industry. DHC outperforms 83.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 |
3. DHC Growth Analysis
3.1 Past
- The earnings per share for DHC have decreased by -4.76% in the last year.
- Looking at the last year, DHC shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
- Measured over the past years, DHC shows a decrease in Revenue. The Revenue has been decreasing by -1.18% on average per year.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
3.2 Future
- DHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.95% yearly.
- Based on estimates for the next years, DHC will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. DHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for DHC. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- DHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DHC is more expensive than 67.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.28 |
4.3 Compensation for Growth
- DHC's earnings are expected to grow with 23.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A
5. DHC Dividend Analysis
5.1 Amount
- DHC has a yearly dividend return of 0.54%, which is pretty low.
- Compared to an average industry Dividend Yield of 7.30, DHC's dividend is way lower than its industry peers. On top of this 93.50% of the companies listed in the same industry pay a better dividend than DHC!
- With a Dividend Yield of 0.54, DHC pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
- The dividend of DHC decreases each year by -25.96%.
- DHC has paid a dividend for at least 10 years, which is a reliable track record.
- DHC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- DHC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.38%
EPS Next 2Y23.95%
EPS Next 3YN/A
DHC Fundamentals: All Metrics, Ratios and Statistics
6.71
-0.44 (-6.15%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners79.52%
Inst Owner Change3.04%
Ins Owners0.48%
Ins Owner Change-8.52%
Market Cap1.62B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target5.87 (-12.52%)
Short Float %2.87%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-26 2026-01-26 (0.01)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)4.35%
EPS NY rev (3m)4.35%
Revenue NQ rev (1m)-4.49%
Revenue NQ rev (3m)-4.31%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.98 | ||
| P/tB | 0.98 | ||
| EV/EBITDA | 17.28 |
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -17.16% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.11% | ||
| FCFM | N/A |
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.3 | ||
| Cap/Depr | 56.06% | ||
| Cap/Sales | 9.55% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 | ||
| Altman-Z | -0.22 |
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1793.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A
DIVERSIFIED HEALTHCARE TRUST / DHC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE TRUST?
ChartMill assigns a fundamental rating of 2 / 10 to DHC.
Can you provide the valuation status for DIVERSIFIED HEALTHCARE TRUST?
ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE TRUST (DHC). This can be considered as Overvalued.
How profitable is DIVERSIFIED HEALTHCARE TRUST (DHC) stock?
DIVERSIFIED HEALTHCARE TRUST (DHC) has a profitability rating of 0 / 10.
Can you provide the financial health for DHC stock?
The financial health rating of DIVERSIFIED HEALTHCARE TRUST (DHC) is 3 / 10.
Can you provide the expected EPS growth for DHC stock?
The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE TRUST (DHC) is expected to grow by 49.5% in the next year.